SCHEMBL13633524

SCHEMBL13633524

CCOC(=O)c1cn2c(C(=O)OCC)cc(Br)cc2n1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.54
KDM4E B2RXH2 6/20 0.50
POLB P06746 1/20 0.50
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GABRA2 P47869 4/20 0.42
GABRB2 P47870 4/20 0.42
CYP1A2 P05177 1/20 0.42
RAB9A P51151 4/20 0.42
NPC1 O15118 3/20 0.42
RXFP1 Q9HBX9 1/20 0.42
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
ADORA2A P29274 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13633525 0.91 GAA (0.51) GAAKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL13633523 0.88 GAA (0.48) GAAKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL1282454 0.85 GAA (0.53) GAAKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL1283036 0.85 GAA (0.53) GAAKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL13633555 0.82 GAA (0.50) GAAKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL13633460 0.80 GAA (0.51) GAAKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL3498812 0.78 GAA (0.54) GAAKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL26071660 0.78 GAA (0.54) GAAKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL1283095 0.78 GAA (0.48) GAAKDM4EPOLBALDH1A1SMN1; SMN2
SCHEMBL30366650 0.77 GAA (0.53) GAAKDM4EPOLBALDH1A1GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS PFIZER INC 2009-11-05 US disclosed
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS PFIZER INC 2009-11-05 US disclosed
US-7563788-B2 Substituted Imidazo[1,2-a]pyridines as Antibacterial Agents PFIZER INC. (US) 2009-07-21 US disclosed
US-20070191394-A1 Antibacterial agents WARNER-LAMBERT COMPANY LLC 2007-08-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191394-A1 Antibacterial agents MRPL21, RPN2, FBL GAA 91/4885KDM4E 4500/4885POLB 569/4885
US-20090275577-A1 IMIDAZOPYRIDINE AND IMIDAZOPYRIMIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS DPYD, TYMP, ITPA GAA 351/4885KDM4E 4078/4885POLB 640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.